Pediatrix Medical Group, Inc. (MD) reported earnings 30 days ago. What's next for the stock?
Pediatrix's (MD) Q4 results were hit by an increase in overall cost level resulting from higher same-unit clinical compensation costs. Yet, an impressive 2024 adjusted EBITDA guidance is likely to pro
Although the revenue and EPS for Pediatrix Medical Group (MD) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare
Pediatrix Medical's (MD) Q4 results are likely to be hurt by an increase in practice salaries and benefits expense as well as softer patient volumes, partly offset by same-unit pricing growth.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2023 Fourth Quarter Conference Call/Webcast Scheduled for Tuesday, February 20, 2024.
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Pediatrix's (MD) third-quarter results suffer from the decline in same-unit revenues attributable to patient volume. Management currently expects 2023 adjusted EBITDA to be within $200-$210 million.
Pediatrix Medical Group, Inc. (NYSE:MD ) Q3 2023 Earnings Conference Call November 2, 2023 9:00 AM ET Company Participants Charles Lynch - Senior Vice President, Finance and Strategy Dr. Jim Swift - C
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.40 per share a year ago.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, November 2, 2023 at 9:00 a.m. ET to discuss resu
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Doximity (DOCS). But which of these two stocks presents investors with the better va
Start Time: 09:00 January 1, 0000 9:26 AM ET Pediatrix Medical Group, Inc. (NYSE:MD ) Q2 2023 Earnings Conference Call August 03, 2023, 09:00 AM ET Company Participants Jim Swift - CEO Marc Richards -
The headline numbers for Pediatrix Medical Group (MD) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall St
Pediatrix (MD) reiterates adjusted EBITDA guidance in the range of $235-$245 million for 2023 compared with $241 million in 2022.
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.39 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.47 per share a year ago.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE